Tetrahydrofuran → HCID 21072811、化合物
反応式
[CH2:1]([O:8][C:9]1[CH:10]=[C:11]([C:20](=[O:26])[CH:21](OCC)O)[C:12]2[O:17][CH2:16][C:15](=[O:18])[NH:14][C:13]=2[CH:19]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[NH2:27][C:28]([CH3:48])([CH3:47])[CH2:29][CH2:30][N:31]1[C:36]2[CH:37]=[C:38]([F:41])[CH:39]=[CH:40][C:35]=2[C:34]([CH2:44][CH3:45])([CH2:42][CH3:43])[O:33][C:32]1=[O:46].C1COCC1.[BH4-].[Li+]>O.ClCCl>[CH2:1]([O:8][C:9]1[CH:10]=[C:11]([CH:20]([OH:26])[CH2:21][NH:27][C:28]([CH3:48])([CH3:47])[CH2:29][CH2:30][N:31]2[C:36]3[CH:37]=[C:38]([F:41])[CH:39]=[CH:40][C:35]=3[C:34]([CH2:44][CH3:45])([CH2:42][CH3:43])[O:33][C:32]2=[O:46])[C:12]2[O:17][CH2:16][C:15](=[O:18])[NH:14][C:13]=2[CH:19]=1)[C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1参加物
反応条件
- 温度
- 5 °C
実験手順
A solution of 232 mg (0.649 mmol) 6-benzyloxy-8-(2-ethoxy-2-hydroxy-acetyl)-4H-benzo[1,4]oxazin-3-one and 200 mg (0.649 mmol) 1-(3-amino-3-methyl-butyl)-4,4-diethyl-7-fluoro-1,4-dihydro-benzo[d][1,3]oxazin-2-one in abs. THF (5 mL) is stirred for 2.5 h at RT. The mixture is cooled to 5° C., combined with 60 mg (2.755 mmol) lithium borohydride, heated to RT and stirred for 1 h. The mixture is again cooled to 5° C. and slowly diluted with 15 ml water and 20 mL dichloromethane. The phases are separated and the aqueous phase is extracted with dichloromethane. The combined org. phases are dried with sodium sulphate and concentrated by evaporation in vacuo. The residue is purified by column chromatography (silica gel, dichloromethane/MeOH 95:5).
後処理
- temperatureheated to RT
- temperatureThe mixture is again cooled to 5° C.
- customThe phases are separated
- extractionthe aqueous phase is extracted with dichloromethane
- dry with materialphases are dried with sodium sulphate
- concentrationconcentrated by evaporation in vacuo
- customThe residue is purified by column chromatography (silica gel, dichloromethane/MeOH 95:5)
出典と根拠
- ORDレコード
- ord-1ff931f201fe4d84abd6d0b62eaba292
- 出典データセット
- uspto-grants-2007_01
- 特許番号
- US07160882B2
反応ノート
読み込み中…